These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 24817946)

  • 1. Nrf2 induces cisplatin resistance through activation of autophagy in ovarian carcinoma.
    Bao LJ; Jaramillo MC; Zhang ZB; Zheng YX; Yao M; Zhang DD; Yi XF
    Int J Clin Exp Pathol; 2014; 7(4):1502-13. PubMed ID: 24817946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of autophagy contributes to cisplatin resistance in human ovarian cancer cells.
    Bao L; Jaramillo MC; Zhang Z; Zheng Y; Yao M; Zhang DD; Yi X
    Mol Med Rep; 2015 Jan; 11(1):91-8. PubMed ID: 25322694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RITA plus 3-MA overcomes chemoresistance of head and neck cancer cells via dual inhibition of autophagy and antioxidant systems.
    Shin D; Kim EH; Lee J; Roh JL
    Redox Biol; 2017 Oct; 13():219-227. PubMed ID: 28582730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of LC3-dependent protective autophagy in ovarian cancer cells by protein phosphatase 2A.
    Yin X; Zhang N; Di W
    Int J Gynecol Cancer; 2013 May; 23(4):630-41. PubMed ID: 23518861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABCF2, an Nrf2 target gene, contributes to cisplatin resistance in ovarian cancer cells.
    Bao L; Wu J; Dodson M; Rojo de la Vega EM; Ning Y; Zhang Z; Yao M; Zhang DD; Xu C; Yi X
    Mol Carcinog; 2017 Jun; 56(6):1543-1553. PubMed ID: 28112439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3-MA Enhanced Chemosensitivity in Cisplatin Resistant Hypopharyngeal Squamous Carcinoma Cells via Inhibiting Beclin -1 Mediated Autophagy.
    Zhang J; Mao W; Liu Y; Ding J; Wang J; Yu Z; Huang R; Yang S; Sun Y; Dong P
    Curr Pharm Des; 2021; 27(7):996-1005. PubMed ID: 33349212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hexokinase 2 confers resistance to cisplatin in ovarian cancer cells by enhancing cisplatin-induced autophagy.
    Zhang XY; Zhang M; Cong Q; Zhang MX; Zhang MY; Lu YY; Xu CJ
    Int J Biochem Cell Biol; 2018 Feb; 95():9-16. PubMed ID: 29247711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination erlotinib-cisplatin and Atg3-mediated autophagy in erlotinib resistant lung cancer.
    Lee JG; Wu R
    PLoS One; 2012; 7(10):e48532. PubMed ID: 23119048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ailanthone increases oxidative stress in CDDP-resistant ovarian and bladder cancer cells by inhibiting of Nrf2 and YAP expression through a post-translational mechanism.
    Cucci MA; Grattarola M; Dianzani C; Damia G; Ricci F; Roetto A; Trotta F; Barrera G; Pizzimenti S
    Free Radic Biol Med; 2020 Apr; 150():125-135. PubMed ID: 32101771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of ATG14 by EGR1-MIR152 sensitizes ovarian cancer cells to cisplatin-induced apoptosis by inhibiting cyto-protective autophagy.
    He J; Yu JJ; Xu Q; Wang L; Zheng JZ; Liu LZ; Jiang BH
    Autophagy; 2015; 11(2):373-84. PubMed ID: 25650716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. shRNA-mediated AMBRA1 knockdown reduces the cisplatin-induced autophagy and sensitizes ovarian cancer cells to cisplatin.
    Li X; Zhang L; Yu L; Wei W; Lin X; Hou X; Tian Y
    J Toxicol Sci; 2016 Feb; 41(1):45-53. PubMed ID: 26763392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapeutic resistance of head and neck squamous cell carcinoma is mediated by EpCAM induction driven by IL-6/p62 associated Nrf2-antioxidant pathway activation.
    Noman ASM; Parag RR; Rashid MI; Islam S; Rahman MZ; Chowdhury AA; Sultana A; Jerin C; Siddiqua A; Rahman L; Nayeem J; Akther S; Baidya S; Shil RK; Rahman M; Shirin A; Mahmud R; Hossain SMI; Sumi SA; Chowdhury A; Basher SB; Hasan A; Bithy S; Aklima J; Chowdhury N; Hasan MN; Banu T; Chowdhury S; Hossain MM; Yeger H; Farhat WA; Islam SS
    Cell Death Dis; 2020 Aug; 11(8):663. PubMed ID: 32814771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nrf2 induced cisplatin resistance in ovarian cancer by promoting CD99 expression.
    Wu J; Zhang L; Li H; Wu S; Liu Z
    Biochem Biophys Res Commun; 2019 Oct; 518(4):698-705. PubMed ID: 31472965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between p53 and Ras signaling controls cisplatin resistance via HDAC4- and HIF-1α-mediated regulation of apoptosis and autophagy.
    Zhang X; Qi Z; Yin H; Yang G
    Theranostics; 2019; 9(4):1096-1114. PubMed ID: 30867818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutant p53 confers chemoresistance in non-small cell lung cancer by upregulating Nrf2.
    Tung MC; Lin PL; Wang YC; He TY; Lee MC; Yeh SD; Chen CY; Lee H
    Oncotarget; 2015 Dec; 6(39):41692-705. PubMed ID: 26497680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of chloride channel 3 expression facilitates sensitivity of human glioma U251 cells to cisplatin through concomitant inhibition of Akt and autophagy.
    Su J; Xu Y; Zhou L; Yu HM; Kang JS; Liu N; Quan CS; Sun LK
    Anat Rec (Hoboken); 2013 Apr; 296(4):595-603. PubMed ID: 23408563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osthole promotes the suppressive effects of cisplatin on NRF2 expression to prevent drug-resistant cervical cancer progression.
    Su J; Zhang F; Li X; Liu Z
    Biochem Biophys Res Commun; 2019 Jun; 514(2):510-517. PubMed ID: 31056260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ursolic acid sensitizes cisplatin-resistant HepG2/DDP cells to cisplatin via inhibiting Nrf2/ARE pathway.
    Wu S; Zhang T; Du J
    Drug Des Devel Ther; 2016; 10():3471-3481. PubMed ID: 27822011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Wogonoside reverses cisplatin resistance in SGC7901/cDDP cells through inhibition of PI3K/Akt/Nrf2/ARE signaling pathway].
    Wang LJ; Wang SG; Deng TX
    Sheng Li Xue Bao; 2018 Aug; 70(4):397-405. PubMed ID: 30112565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of autophagy augments chemotherapy in human salivary adenoid cystic carcinoma.
    Jiang L; Huang S; Zhang D; Zhang B; Li K; Li W; Zhang S; Zhang W; Zheng P
    J Oral Pathol Med; 2014 Apr; 43(4):265-72. PubMed ID: 24118359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.